Hypera SA (OTCPK:HYPMY)
$ 3.85 -0.04 (-1.03%) Market Cap: 2.44 Bil Enterprise Value: 3.69 Bil PE Ratio: 7.36 PB Ratio: 1.18 GF Score: 81/100

Q3 2019 Hypera SA Earnings Call Transcript

Oct 28, 2019 / 02:00PM GMT
Release Date Price: $8.56 (-1.50%)
Operator

Good morning. Welcome to the Hypera Pharma Third Quarter of 2019 Results Conference Call. We have Mr. Breno Oliveira, CEO; and Mr. Adalmario Couto, CFO; and IRO are here with us today. We would like to inform you that this event is being recorded. (Operator Instructions) We also would like to inform that statements during the conference may be considered forward-looking statements. Such statements are subject to known and unknown risks and uncertainties that could cause the company's actual results to differ materially from those set forward in the forward-looking statements.

I would like now to turn over to Mr. Breno Oliveira. Mr. Breno Oliveira, you have the floor.

Breno Toledo Pires de Oliveira
Hypera S.A. - CEO

Good morning. Welcome to our Q3 teleconference call. Before I start talking about the operational performance, let me give you an update of our independent committee. We are expected to conclude the project by year's end.

Let me move on to the operational portion on Slide 3. Our sell-out grew by 11% in Q3, about 10% for the second

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot